Jean-François Lévesque

853 total citations
24 papers, 496 citations indexed

About

Jean-François Lévesque is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Jean-François Lévesque has authored 24 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Jean-François Lévesque's work include Pharmacogenetics and Drug Metabolism (8 papers), Receptor Mechanisms and Signaling (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Jean-François Lévesque is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Receptor Mechanisms and Signaling (8 papers) and Inflammatory mediators and NSAID effects (7 papers). Jean-François Lévesque collaborates with scholars based in Canada and United States. Jean-François Lévesque's co-authors include Kevin P. Bateman, Deborah A. Nicoll‐Griffith, Nathalie Chauret, Sébastien Gagné, Carl Berthelette, Yongxin Han, Jin Wu, Christopher S. Hughes, Pierre Picard and Danielle Goudreault and has published in prestigious journals such as Analytical Chemistry, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Jean-François Lévesque

24 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-François Lévesque Canada 13 140 116 106 93 87 24 496
S.-E. W. Huskey United States 8 193 1.4× 36 0.3× 55 0.5× 81 0.9× 82 0.9× 9 454
Jeffrey Sarver United States 13 204 1.5× 48 0.4× 66 0.6× 34 0.4× 47 0.5× 34 529
Marc Bertrand France 15 301 2.1× 64 0.6× 87 0.8× 52 0.6× 71 0.8× 25 838
Alan P. Breau United States 16 207 1.5× 240 2.1× 87 0.8× 37 0.4× 91 1.0× 31 641
M. Reza Anari Canada 13 222 1.6× 35 0.3× 68 0.6× 56 0.6× 161 1.9× 17 647
Takashi Mizuma Japan 14 351 2.5× 107 0.9× 77 0.7× 60 0.6× 53 0.6× 61 864
Shih-Jung Lan United States 11 206 1.5× 41 0.4× 140 1.3× 35 0.4× 46 0.5× 18 566
Richard M. Hindley Australia 14 626 4.5× 152 1.3× 235 2.2× 100 1.1× 45 0.5× 21 908
Giorgio Ottaviani Switzerland 14 189 1.4× 104 0.9× 144 1.4× 43 0.5× 68 0.8× 22 635
Mitsuru Tateishi Japan 16 300 2.1× 60 0.5× 72 0.7× 27 0.3× 40 0.5× 51 704

Countries citing papers authored by Jean-François Lévesque

Since Specialization
Citations

This map shows the geographic impact of Jean-François Lévesque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-François Lévesque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-François Lévesque more than expected).

Fields of papers citing papers by Jean-François Lévesque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-François Lévesque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-François Lévesque. The network helps show where Jean-François Lévesque may publish in the future.

Co-authorship network of co-authors of Jean-François Lévesque

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-François Lévesque. A scholar is included among the top collaborators of Jean-François Lévesque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-François Lévesque. Jean-François Lévesque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chauret, Nathalie, et al.. (2015). In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions. Drug Metabolism and Disposition. 43(12). 1960–1965. 10 indexed citations
2.
Cauchon, Elizabeth, Austin Chen, Amandine Chefson, et al.. (2012). Design and synthesis of potent, isoxazole-containing renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(8). 2670–2674. 9 indexed citations
3.
Aspiotis, Renée, Austin Chen, Elizabeth Cauchon, et al.. (2011). The discovery and synthesis of potent zwitterionic inhibitors of renin. Bioorganic & Medicinal Chemistry Letters. 21(8). 2430–2436. 7 indexed citations
4.
Lévesque, Jean-François, Kelly Bleasby, Amandine Chefson, et al.. (2011). Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters. 21(18). 5547–5551. 9 indexed citations
5.
Chen, Austin, Renée Aspiotis, Louis‐Charles Campeau, et al.. (2011). Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of spirocyclic piperidines. Bioorganic & Medicinal Chemistry Letters. 21(24). 7399–7404. 11 indexed citations
6.
Leblanc, Yves, Carl Berthelette, Carmela Molinaro, et al.. (2010). Azaindoles as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 841–845. 21 indexed citations
7.
Burch, Jason D., John Colucci, Claudio F. Sturino, et al.. (2010). Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 21(3). 1041–1046. 12 indexed citations
8.
Lévesque, Jean-François, et al.. (2010). Protocols of In Vitro Protein Covalent Binding Studies in Liver. Methods in molecular biology. 691. 283–301. 2 indexed citations
9.
Robichaud, Joël, Jean‐François Fournier, Sébastien Gagné, et al.. (2010). Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14. Bioorganic & Medicinal Chemistry Letters. 21(14). 4366–4368. 44 indexed citations
10.
Colucci, John, Michael J. Boyd, Carl Berthelette, et al.. (2010). Discovery of 4-{1-[({1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl}carbonyl)amino]cyclopropyl}benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 20(12). 3760–3763. 29 indexed citations
11.
Blouin, Marc, Yongxin Han, Jason D. Burch, et al.. (2010). The Discovery of 4-{1-[({2,5-Dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic Acid (MK-2894), A Potent and Selective Prostaglandin E2Subtype 4 Receptor Antagonist. Journal of Medicinal Chemistry. 53(5). 2227–2238. 29 indexed citations
12.
Chauret, Nathalie, David Claveau, Stephen H. Day, et al.. (2009). Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5266–5269. 2 indexed citations
13.
Gagné, Sébastien, Louiza Mahrouche, Dan Sørensen, et al.. (2008). Selective isolation of in vitro phase II conjugates using a lipophilic anionic exchange solid phase extraction method. Journal of Chromatography B. 863(2). 242–248. 5 indexed citations
14.
Burch, Jason D., Michel Belley, Réjean Fortin, et al.. (2008). Structure–activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 18(6). 2048–2054. 15 indexed citations
15.
Lévesque, Jean-François, Stephen H. Day, Nathalie Chauret, et al.. (2007). Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: Impacts of glutathione trapping and glucuronide conjugation on covalent binding. Bioorganic & Medicinal Chemistry Letters. 17(11). 3038–3043. 20 indexed citations
16.
Crane, Sheldon N., Kevin P. Bateman, Sébastien Gagné, & Jean-François Lévesque. (2006). Preparation of deuterium‐labeled monounsaturated and saturated fatty acids for use as stable isotope metabolic tracers. Journal of Labelled Compounds and Radiopharmaceuticals. 49(14). 1273–1285. 6 indexed citations
17.
Gagné, Sébastien, Sheldon N. Crane, Zheng Huang, et al.. (2006). Rapid measurement of deuterium-labeled long-chain fatty acids in plasma by HPLC-ESI-MS. Journal of Lipid Research. 48(1). 252–259. 29 indexed citations
18.
Lévesque, Jean-François, et al.. (2005). Discovery, biosynthesis, and structure elucidation of new metabolites of norandrostenedione using in vitro systems. Steroids. 70(4). 305–317. 18 indexed citations
19.
20.
Houle, Robert, Jean‐Luc Raoul, Jean-François Lévesque, et al.. (2003). Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes. Drug Metabolism and Disposition. 31(4). 447–451. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.-E. W. Huskey Breakdown of academic impact, for papers by Jeffrey Sarver Breakdown of academic impact, for papers by Marc Bertrand Breakdown of academic impact, for papers by Alan P. Breau Breakdown of academic impact, for papers by M. Reza Anari Breakdown of academic impact, for papers by Takashi Mizuma Breakdown of academic impact, for papers by Shih-Jung Lan Breakdown of academic impact, for papers by Richard M. Hindley Breakdown of academic impact, for papers by Giorgio Ottaviani Breakdown of academic impact, for papers by Mitsuru Tateishi
Rankless by CCL
2026